Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 20:4:1043-6.
doi: 10.2147/opth.s13193.

Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation

Affiliations

Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation

Takaki Kobayashi et al. Clin Ophthalmol. .

Abstract

Purpose: To determine the intravitreal levels of vascular endothelial growth factor (VEGF) in eyes with anterior hyaloidal fibrovascular proliferation (AHFVP).

Methods: Three eyes of three patients who underwent vitrectomy for proliferative diabetic retinopathy (PDR) and subsequently developed an AHFVP (AHFVP group) were studied. We measured the level of VEGF in vitreous samples collected at the primary and following operations by enzyme-linked immunosorbent assay. The vitreous levels of VEGF in 25 eyes of 22 patients with PDR were also studied as controls (PDR group).

Results: The averaged VEGF level in the samples collected at the primary surgery was 1.98 ± 2.23 ng/mL in the PDR group, and it was 9.07, 1.94, and 8.07 ng/mL in the AHFVP cases. After the primary surgery, the VEGF level rose up to 49.50, 15.60, and 50.60 ng/mL at the subsequent surgeries for respective cases of the AHFVP group. These levels of VEGF were more than five times higher than the baseline at the primary surgery.

Conclusion: The subsequent increase of the VEGF level after the primary surgery in eyes with an AHFVP suggests that the vitreous levels of VEGF are associated with the development of the AHFVP although only three eyes were studied.

Keywords: AHFVP; VEGF; diabetic retinopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intraoperative photograph of Case 1 with AHFVP undergoing membrane removal with vitreous cutter. Abbreviation: AHFVP, anterior hyaloidal fibrovascular proliferation.
Figure 2
Figure 2
VEGF level in the vitreous are plotted for the PDR group (circles) and AHFVP group measured at each operation (open square). Abbreviations: VEGF, vascular endothelial growth factor; PDR, proliferative diabetic retinopathy; AHFVP, anterior hyaloidal fibrovascular proliferation.

Similar articles

Cited by

References

    1. Lewis H, Abrams GW, Wiliams GA. Anterior hyaloidal fibrovascular proliferation after diabetic retinoathy. Am J Ophthalmol. 1987;104:607–615. - PubMed
    1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487. - PubMed
    1. Funatsu H, Yamashita H, Noma H, et al. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II. Br J Ophthalmol. 2004;88:1064–1068. - PMC - PubMed
    1. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res. 1995;14:1015–1020. - PubMed
    1. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol. 1997;17:4015–4023. - PMC - PubMed

LinkOut - more resources